Efficacy of targeted chemokine receptor 4 PET/CT in evaluating active lesions in multiple myeloma, comparison to (18)F-FDG PET/CT.
A specialized PET scan targeting a specific cancer protein showed promise for detecting myeloma lesions more accurately than standard imaging.
This study compares CXCR4-targeted PET/CT to standard 18F-FDG PET/CT for detecting active lesions in multiple myeloma patients at a Chinese academic center. CXCR4-targeted PET represents an emerging precision imaging approach for MM, though full results are unknown from abstract alone.
What the study was
- Study design
- Comparative imaging study (CXCR4-targeted PET/CT vs FDG PET/CT in MM)
- Population
- Multiple myeloma patients at Soochow University First Affiliated Hospital
- Category
- Diagnostics
- Maturity
- Exploratory
- Journal
- Cancer Imaging
Why it surfaced
Score hard-capped at 3 per title-only rule. CXCR4 PET/CT in MM is an active research area of genuine interest; recommend re-evaluation when full abstract is available.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.